Merck & Co., Inc. (FRA:6MK)
71.50
+0.30 (0.42%)
Last updated: Jul 10, 2025
Merck & Co. Revenue
Merck & Co. had revenue of $15.53B USD in the quarter ending March 31, 2025, a decrease of -1.56%. This brings the company's revenue in the last twelve months to $63.92B, up 4.10% year-over-year. In the year 2024, Merck & Co. had annual revenue of $64.17B with 6.74% growth.
Revenue (ttm)
$63.92B
Revenue Growth
+4.10%
P/S Ratio
2.98
Revenue / Employee
$852.29K
Employees
75,000
Market Cap
176.29B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Siemens Healthineers AG | 23.14B |
Merck & Co. News
- 7 days ago - Verona Pharma (VRNA) Downgraded as Merck Plans $10B Acquisition | VRNA Stock News - GuruFocus
- 7 days ago - Merck to acquire Verona Pharma for $10B in diversification move - CNBC
- 7 days ago - US pharma giant Merck snaps up London lung specialist Verona Pharma for £7.5bn - This is Money
- 7 days ago - Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps - Benzinga
- 7 days ago - P/E Ratio Insights for Merck & Co - Benzinga
- 7 days ago - Major deals involving U.S. drugmakers and biotechs over the past decade - Reuters
- 7 days ago - Undercovered Dozen: Roku, Merck, Chevron And More - Seeking Alpha
- 7 days ago - VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders - Wallstreet:Online